Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 2.5 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 5 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 7.5 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 10 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 15 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 20 mg - immunosuppressants

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 25 mg - immunosuppressants

Singapore - English - HSA (Health Sciences Authority)

pharmline marketing pte. ltd. - general & plastic surgery - wound care device based on zinc-hyaluronate. it is intended for management and protection of compromised or problem skin, and support of the healing of acute and chronic wounds. for over-the-counter use: (i) compromised skin (eg radiation induced irritation, dryness, desquamation) (ii) superficial wounds such as minor traumatic wounds (abrasions, lacerations, cuts), minor burns (first and second degree burns) (iii) mild-to-moderate form of acne vulgaris. under the supervision of a healthcare professional: (i) chronic wounds such as leg ulcers of different origin and decubitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 225 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.